Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Net Debt / (EBITDA-CAPEX)

Acadia Pharmaceutica Net Debt / (EBITDA-CAPEX) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Acadia Pharmaceutica Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $4m a -6.54% decrease of 0m year over year
  • Acadia Pharmaceutica Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $3m a 4.49% increase of 0m year over year
  • Acadia Pharmaceutica Annual Net Debt / (EBITDA-CAPEX) for 2019 was $3m a 33.05% increase of 1m from 2018
  • Acadia Pharmaceutica Annual Net Debt / (EBITDA-CAPEX) for 2018 was $2m a 38.81% increase of 1m from 2017
  • Acadia Pharmaceutica Annual Net Debt / (EBITDA-CAPEX) for 2017 was $1m a -65.23% decrease of -1m from 2016
Other Ratios Metrics:
  • Acadia Pharmaceutica Total Debt / Capital for the quarter ending September 09, 2012 was $0m a -708.88% decrease of 0m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Debt / Equity for the quarter ending September 09, 2012 was $0m a -710.06% decrease of 0m year over year
View Chart On Koyfin

Quarterly ACAD Net Debt / (EBITDA-CAPEX) Data

06/2020$4m
03/2020$2m
12/2019$3m
09/2019$4m
06/2019$2m
03/2019$1m
12/2018$2m
09/2018$1m
06/2018$1m
03/2018$1m

Annual ACAD Net Debt / (EBITDA-CAPEX) Data

2019$3m
2018$2m
2017$1m
2016$2m
2015$1m
2014$3m
2013$5m
2012$5m
2011$1m
2010$-2m